Taylor & Francis Group
Browse
Supplementary_Material_file_NIRVANA-1_trial.docx (26.41 kB)

NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material

Download (26.41 kB)
dataset
posted on 2023-08-31, 13:37 authored by Syrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, Myong Cheol Lim, Kosei Hasegawa, Els Van Nieuwenhuysen, Antonio Gonzalez, Francesco Raspagliesi, Gilles Freyer

Criteria for discontinuing allocated interventions for participant and dose modifications

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC